Huateng Pharma Unveils Y-Shape PEG NHS for Enhanced Drug PEGylation

Huateng Pharma has launched Y-Shape PEG NHS, an advanced PEGylation solution that enhances protein drug development by improving water solubility and biocompatibility through efficient and selective modification of proteins.

‘Biolyst Scientific’ Announced as New Brand Name to Encompass EMS and Azer, Will Deepen Offerings to Clinical and Research Lab Customers

Biolyst Scientific today announced its new brand name, reflecting the integration of Electron Microscopy Sciences (EMS) and Azer Scientific.

firefly® chosen by PRISM BioLab to expedite discovery screening workflows

Placement of the first firefly platform in Japan expands SPT Labtech’s growing global liquid handling community

Biora Therapeutics Announces Supplemental Data from Phase 1 Clinical Trial of BT-600 as Presented at KOL Event

Pharmacokinetic and tissue data confirm NaviCap platform delivers topically through the entire colon, with lower systemic concentrations, as desired Data modeling suggests tofacitinib tissue concentrations greater than IC90 through at least 16 hours after dosing

Nipro Announces Major Expansion with New Medical Device Manufacturing Facility in Greenville, North Carolina, USA

Envision Pharma Group launches 4Sight to drive AI and technology performance in healthcare

One of the world's leading providers of technology solutions Envision Pharma Group has announced the launch of 4Sight, a new form of AI-enabled technology to unlock the full potential of data and insights in medical affairs.

BOC Sciences Chemistry Scholarship Program of 2024 Announced

BOC Sciences is pleased to announce its new Scholarship Program aimed at supporting college students pursuing degrees in chemistry-related fields. This prestigious scholarship awards $1,000 annually to help these aspiring chemists achieve their academic goals and make a difference in the scientific community.

Sapio Sciences Launches Partner Program to Accelerate Research and Diagnostics

Sapio Sciences, the science-aware™ lab informatics platform, today announced the Sapio Sciences Partner Program. The program provides a growing partner ecosystem of technology vendors, services companies, and resellers with the tools, training, support, and marketing services to deliver solutions that empower scientists.

Intelliguard Unveils Enhanced Suite of Medication Management and Data Intelligence Solutions to Ensure an Environment of Safety for Hospitals and Patients

Intelliguard, a proven provider of medication management and data intelligence solutions, has unveiled its Mira Ecosystem, a reimagined product line of innovative and integrated solutions for hospitals and healthcare systems that support increased patient safety and operational efficiency.

Integrated DNA Technologies Announces New Licensing Agreement with SeQure Dx to Advance CRISPR-based Therapeutics

IDT inks licensing agreement with SeQure Dx to support cell and gene therapy developers through all stages of their CRISPR-based therapeutic programs.

Avallano releases ProtocolCopilot™: Powering Clinical Research with AI-driven Protocol Assistance

Avallano is launching ProtocolCopilot™, an innovative AI-driven clinical research protocol assistant designed to transform the way biopharmaceutical companies and clinical research sites manage and interact with complex clinical trial protocols.

Optibrium Appoints James Halle as Chief Commercial Officer

Optibrium, a leading developer of software and AI solutions for drug discovery and molecular design, today announced the appointment of James Halle as Chief Commercial Officer (CCO). James brings extensive software experience in the pharma industry and will guide the commercial success of the company.

1upHealth Achieves HITRUST Implemented, 1-year (i1) Certification to Manage Data Protection and Mitigate Cybersecurity Threats

Synexa Life Sciences Enrols in My Green Lab Certification Program

Synexa Life Sciences has announced its enrolment in the My Green Lab Certification Program.

Surfix Diagnostics, the Netherlands Cancer Institute and CRCbioscreen join forces to validate biomarkers for colorectal cancer screening

Surfix Diagnostics alongside the Netherlands Cancer Institute (NKI) and CRCbioscreen, announced a collaboration aimed at enhancing colorectal cancer (CRC) screening methods.

ZYMO RESEARCH LAUNCHES THE OMICS DISCOVERY GRANT TO ADVANCE RNA-SEQ RESEARCH

https://www.zymoresearch.com/blogs/press-releases/omics-discovery-grant-launch Apply for Zymo Research's Omics Discovery Grant for cutting-edge RNA-Seq tools worth $4000.

SMi Systems appoints Dr Stefan Hamill as VP of Strategy

SMi Systems announces the appointment of Dr Stefan Hamill as its Vice President of Strategy. Dr Hamill was formerly a senior analyst at investment banks Numis (now Deutsche Numis) and Peel Hunt, both of which he helped transform into #1 ranked franchises in UK Life Sciences.

Cotiviti’s Quality Intelligence Earns NCQA Certified Measures Status for HEDIS® Measurement Year 2024

DoseMe Achieves HITRUST Risk-Based, 2-year (r2) Certification

DoseMe, a leading provider of model-informed precision dosing (MIPD), announced today it has earned certified status by HITRUST for information security. HITRUST Risk-based, 2-year (r2) Certification demonstrates that the organization’s DoseMeRX has met demanding regulatory compliance and industry-defined requirements and is appropriately managing risk. This achievement places DoseMe in an elite group of organizations worldwide that have earned this certification. By including federal and state regulations, standards, and frameworks and incorporating a risk-based approach, the HITRUST Assurance Program helps organizations address security and data protection challenges through a comprehensive and flexible framework of prescriptive and scalable security controls. DoseMe remains the only model informed precision dosing platform to achieve the r2 Certification.

Personalized Obesity Care Genetic Testing Available to Women in New Phenomix Sciences and Hello Alpha Partnership

The first-of-its-kind collaboration combines personalized genetic insights with evidence-based treatments to provide accessible and effective obesity care for women